Page last updated: 2024-11-01

nimodipine and Breathlessness

nimodipine has been researched along with Breathlessness in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Escribano, AB1
Peña, E1
Barbosa, A1
Fernández, C1

Other Studies

1 other study available for nimodipine and Breathlessness

ArticleYear
Puerpera with dyspnoea and epileptic seizure.
    Neurologia (Barcelona, Spain), 2013, Volume: 28, Issue:5

    Topics: Adult; Calcium Channel Blockers; Cerebrovascular Disorders; Coronary Angiography; Dyspnea; Epilepsy;

2013